000 01677 a2200469 4500
005 20250514163852.0
264 0 _c20040422
008 200404s 0 0 eng d
022 _a0301-0546
024 7 _a10.1016/s0301-0546(03)79207-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSambugaro, R
245 0 0 _aThe efficacy of sublingual immunotherapy for respiratory allergy is not affected by different dosage regimens in the induction phase.
_h[electronic resource]
260 _bAllergologia et immunopathologia
_c
300 _a329-37 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Sublingual
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAllergens
_xadministration & dosage
650 0 4 _aAsthma
_xtherapy
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aConjunctivitis, Allergic
_xtherapy
650 0 4 _aDesensitization, Immunologic
_xmethods
650 0 4 _aDose-Response Relationship, Immunologic
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aForced Expiratory Volume
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aRhinitis, Allergic, Perennial
_xtherapy
650 0 4 _aRhinitis, Allergic, Seasonal
_xtherapy
650 0 4 _aSafety
650 0 4 _aSkin Tests
650 0 4 _aTreatment Outcome
700 1 _aPuccinelli, P
700 1 _aBurastero, S E
700 1 _aDi Rienzo, V
773 0 _tAllergologia et immunopathologia
_gvol. 31
_gno. 6
_gp. 329-37
856 4 0 _uhttps://doi.org/10.1016/s0301-0546(03)79207-6
_zAvailable from publisher's website
999 _c14403043
_d14403043